Home/Filings/4/0000950170-24-115597
4//SEC Filing

Palasis Maria 4

Accession 0000950170-24-115597

CIK 0001327273other

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 4:05 PM ET

Size

5.2 KB

Accession

0000950170-24-115597

Insider Transaction Report

Form 4
Period: 2024-10-16
Palasis Maria
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    2024-10-16+300,000300,000 total
Footnotes (1)
  • [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three substantially equal installments occurring on April 1, 2025, October 1, 2025 and April 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Documents

1 file

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

Entity typeother

Related Parties

1
  • filerCIK 0001810701

Filing Metadata

Form type
4
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:05 PM ET
Size
5.2 KB